Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 325 to 328 of 328 entries
Sorted by: Best Match Show Resources per page
Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer-How Low-Cost Must MRI Be?.

Cancers

Tollens F, Baltzer PAT, Dietzel M, Rübenthaler J, Froelich MF, Kaiser CG.
PMID: 33808955
Cancers (Basel). 2021 Mar 12;13(6). doi: 10.3390/cancers13061241.

BACKGROUND: Digital breast tomosynthesis (DBT) and abbreviated breast MRI (AB-MRI) offer superior diagnostic performance compared to conventional mammography in screening women with intermediate risk of breast cancer due to dense breast tissue. The aim of this model-based economic evaluation...

Cite
Tollens F, Baltzer PAT, Dietzel M, et al. Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer-How Low-Cost Must MRI Be?. Cancers (Basel). 2021;13(6)doi: 10.3390/cancers13061241.
Tollens, F., Baltzer, P. A. T., Dietzel, M., Rübenthaler, J., Froelich, M. F., & Kaiser, C. G. (2021). Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer-How Low-Cost Must MRI Be?. Cancers, 13(6), . https://doi.org/10.3390/cancers13061241
Tollens, Fabian, et al. "Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer-How Low-Cost Must MRI Be?." Cancers vol. 13,6 (2021). doi: https://doi.org/10.3390/cancers13061241
Tollens F, Baltzer PAT, Dietzel M, Rübenthaler J, Froelich MF, Kaiser CG. Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer-How Low-Cost Must MRI Be?. Cancers (Basel). 2021 Mar 12;13(6). doi: 10.3390/cancers13061241. PMID: 33808955; PMCID: PMC8000655.
Copy Download .nbib Format: NLM
Introduction to the special issue: "Natural Product Discovery and Development in the Genomic Era: 2021".

Journal of industrial microbiology & biotechnology

Shen B, Tang Y, Baltz RH, Gonzalez R.
PMID: 33904896
J Ind Microbiol Biotechnol. 2021 Jun 04;48(3). doi: 10.1093/jimb/kuab030.

No abstract available.

Cite
Shen B, Tang Y, Baltz RH, et al. Introduction to the special issue: "Natural Product Discovery and Development in the Genomic Era: 2021". J Ind Microbiol Biotechnol. 2021;48(3)doi: 10.1093/jimb/kuab030.
Shen, B., Tang, Y., Baltz, R. H., & Gonzalez, R. (2021). Introduction to the special issue: "Natural Product Discovery and Development in the Genomic Era: 2021". Journal of industrial microbiology & biotechnology, 48(3), . https://doi.org/10.1093/jimb/kuab030
Shen, Ben, et al. "Introduction to the special issue: "Natural Product Discovery and Development in the Genomic Era: 2021"." Journal of industrial microbiology & biotechnology vol. 48,3 (2021). doi: https://doi.org/10.1093/jimb/kuab030
Shen B, Tang Y, Baltz RH, Gonzalez R. Introduction to the special issue: "Natural Product Discovery and Development in the Genomic Era: 2021". J Ind Microbiol Biotechnol. 2021 Jun 04;48(3). doi: 10.1093/jimb/kuab030. PMID: 33904896.
Copy Download .nbib Format: NLM
Coronary CT Fractional Flow Reserve before Transcatheter Aortic Valve Replacement: Clinical Outcomes.

Radiology

Aquino GJ, Abadia AF, Schoepf UJ, Emrich T, Yacoub B, Kabakus I, Violette A, Wiley C, Moreno A, Sahbaee P, Schwemmer C, Bayer RR, Varga-Szemes A, Steinberg D, Amoroso N, Kocher M, Waltz J, Ward TJ, Burt JR.
PMID: 34609200
Radiology. 2022 Jan;302(1):50-58. doi: 10.1148/radiol.2021210160. Epub 2021 Oct 05.

Background The role of CT angiography-derived fractional flow reserve (CT-FFR) in pre-transcatheter aortic valve replacement (TAVR) assessment is uncertain. Purpose To evaluate the predictive value of on-site machine learning-based CT-FFR for adverse clinical outcomes in candidates for TAVR. Materials...

Cite
Aquino GJ, Abadia AF, Schoepf UJ, et al. Coronary CT Fractional Flow Reserve before Transcatheter Aortic Valve Replacement: Clinical Outcomes. Radiology. 2021;302(1):50-58doi: 10.1148/radiol.2021210160.
Aquino, G. J., Abadia, A. F., Schoepf, U. J., Emrich, T., Yacoub, B., Kabakus, I., Violette, A., Wiley, C., Moreno, A., Sahbaee, P., Schwemmer, C., Bayer, R. R., Varga-Szemes, A., Steinberg, D., Amoroso, N., Kocher, M., Waltz, J., Ward, T. J., & Burt, J. R. (2022). Coronary CT Fractional Flow Reserve before Transcatheter Aortic Valve Replacement: Clinical Outcomes. Radiology, 302(1), 50-58. https://doi.org/10.1148/radiol.2021210160
Aquino, Gilberto J, et al. "Coronary CT Fractional Flow Reserve before Transcatheter Aortic Valve Replacement: Clinical Outcomes." Radiology vol. 302,1 (2022): 50-58. doi: https://doi.org/10.1148/radiol.2021210160
Aquino GJ, Abadia AF, Schoepf UJ, Emrich T, Yacoub B, Kabakus I, Violette A, Wiley C, Moreno A, Sahbaee P, Schwemmer C, Bayer RR, Varga-Szemes A, Steinberg D, Amoroso N, Kocher M, Waltz J, Ward TJ, Burt JR. Coronary CT Fractional Flow Reserve before Transcatheter Aortic Valve Replacement: Clinical Outcomes. Radiology. 2022 Jan;302(1):50-58. doi: 10.1148/radiol.2021210160. Epub 2021 Oct 05. PMID: 34609200.
Copy Download .nbib Format: NLM
The diagnostic value of non-contrast magnetic resonance coronary angiography in the assessment of coronary artery disease: A systematic review and meta-analysis.

Heliyon

Zahergivar A, Kocher M, Waltz J, Kabakus I, Chamberlin J, Akkaya S, Agha AM, Schoepf UJ, Burt JR.
PMID: 33817362
Heliyon. 2021 Mar 18;7(3):e06386. doi: 10.1016/j.heliyon.2021.e06386. eCollection 2021 Mar.

PURPOSE: The current literature reports a wide range of diagnostic accuracy of non-contrast magnetic resonance coronary angiography (NC-MRCA) for the assessment of coronary artery disease (CAD). We aimed to compare the clinical effectiveness of NC-MRCA with that of invasive...

Cite
Zahergivar A, Kocher M, Waltz J, et al. The diagnostic value of non-contrast magnetic resonance coronary angiography in the assessment of coronary artery disease: A systematic review and meta-analysis. Heliyon. 2021;7(3):e06386doi: 10.1016/j.heliyon.2021.e06386.
Zahergivar, A., Kocher, M., Waltz, J., Kabakus, I., Chamberlin, J., Akkaya, S., Agha, A. M., Schoepf, U. J., & Burt, J. R. (2021). The diagnostic value of non-contrast magnetic resonance coronary angiography in the assessment of coronary artery disease: A systematic review and meta-analysis. Heliyon, 7(3), e06386. https://doi.org/10.1016/j.heliyon.2021.e06386
Zahergivar, Aryan, et al. "The diagnostic value of non-contrast magnetic resonance coronary angiography in the assessment of coronary artery disease: A systematic review and meta-analysis." Heliyon vol. 7,3 (2021): e06386. doi: https://doi.org/10.1016/j.heliyon.2021.e06386
Zahergivar A, Kocher M, Waltz J, Kabakus I, Chamberlin J, Akkaya S, Agha AM, Schoepf UJ, Burt JR. The diagnostic value of non-contrast magnetic resonance coronary angiography in the assessment of coronary artery disease: A systematic review and meta-analysis. Heliyon. 2021 Mar 18;7(3):e06386. doi: 10.1016/j.heliyon.2021.e06386. eCollection 2021 Mar. PMID: 33817362; PMCID: PMC8010401.
Copy Download .nbib Format: NLM
Showing 325 to 328 of 328 entries